Quantcast

Latest human disease Stories

2014-06-20 08:23:13

~Company Recognized as Notable Recipient of SBIR Grants CHARLOTTESVILLE, Va., June 20, 2014 /PRNewswire/ -- HemoShear, LLC, the human disease biology company, today announced that CBO Vince Aurentz will be presenting at the BIO 2014 meeting during the BIO Business Forum on Tuesday, June 24 at 11:00 a.m. in the Solana Beach Room. Aurentz's presentation, "Recreating Human Disease Biology for Discovery and Development of Safer and More Effective New Drugs", will focus on HemoShear's...

2014-06-18 12:35:23

CHARLOTTESVILLE, Va., June 18, 2014 /PRNewswire/ -- HemoShear, the human disease biology company, has received the prestigious Tibbetts Award, recognizing it as a "Model of Excellence" for the U.S. government's Small Business Innovation Research (SBIR) Program. Over 15,000 companies have received $21 billion of research funding through the SBIR program. Of these companies, only a very small number are chosen as exemplars of the SBIR's mission. Awarded to only 25 companies in 2014, the...

2014-05-29 08:28:50

~State-of-the-art facility to support accelerated growth with industry partners and development of new biological systems CHARLOTTESVILLE, Va., May 29, 2014 /PRNewswire/ -- HemoShear, the human disease biology company, has moved into a newly renovated state-of-the-art facility in Charlottesville to accommodate growth of partnerships with major pharmaceutical and biotechnology companies and expand its R&D capabilities. The facility provides 16,000 sq ft of combined laboratory and...

2014-05-07 08:31:51

~Latest round of financing to support expansion of state-of-the-art facilities and development of new disease systems to address the growing needs of strategic R&D collaborations~ CHARLOTTESVILLE, Va., May 7, 2014 /PRNewswire/ -- HemoShear, the human disease biology company, today announced the completion of a C-1 equity offering raising $8.7 million. Since its inception in 2008, HemoShear has secured a total of $22 million in private equity financing, as well as $10 million in...

2014-04-23 08:31:14

CHARLOTTESVILLE, Va., April 23, 2014 /PRNewswire/ -- HemoShear, LLC, the human disease biology company, today announced research collaboration with Medivir AB of Stockholm, Sweden, an emerging research-based pharmaceutical company focused on infectious diseases. The collaboration will explore the application of HemoShear's platform in an undisclosed area of strategic interest. In this initial phase of the collaboration, HemoShear will characterize biological mechanisms and the effects...

2013-10-04 13:17:31

Studies in fish and cultured human cells provide insight into a human disease Children born with developmental disorders called cohesinopathies can suffer severe consequences, including intellectual disabilities, limb shortening, craniofacial anomalies, and slowed growth. Researchers know which mutations underlie some cohesinopathies, but have developed little understanding of the downstream signals that are disrupted in these conditions. In a study published in the October 3, 2013,...

Zebrafish Genome Could Have Significant Implications For Human Health
2013-04-18 09:59:16

April Flowers for redOrbit.com - Your Universe Online Two new studies from the Wellcome Trust Sanger Institute involving the genome of zebrafish have been published in the journal Nature this week, giving insight into the relationship between humans, zebrafish and genetic mutations. FAMILY TIES According to the first study, 70 percent of protein-coding human genes are related to zebrafish genes, and 84 percent of the genes known to be associated with human disease have a counterpart...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related